<?xml version="1.0" encoding="UTF-8"?>
<p id="par0075">Because there is no definite and specific treatment for patients with COVID-19, some antiviral agents are prescribed to the patients, depending on their condition and location. Among the antiviral agents, remdesivir is the most well-known potential drug for the treatment of patients with COVID-19. For the treatment of Ebola virus infection in 2017, Gilead Sciences synthesized and developed remdesivir, and it is a phosphoramidate prodrug of an adenosine C-nucleoside and a broad spectrum antiviral agent [
 <xref rid="bib0325" ref-type="bibr">65</xref>].
</p>
